A detailed history of Brewin Dolphin Wealth Management LTD transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 2,500 shares of DVAX stock, worth $31,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,500
Previous 2,500 -0.0%
Holding current value
$31,800
Previous $27,000 14.81%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 14, 2022

BUY
$9.75 - $14.44 $24,375 - $36,100
2,500 New
2,500 $27,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.